Europe’s first joint call for ageing research ‘ERA-AGE 2’ has been released with a whopping €4.2M available. Research Councils from across Europe have contributed to this fund which aims to increase healthy ageing and increase life expectancy by two years within the European Union by 2020.
This call enables researchers from all disciplines to put in applications addressing “Active and healthy ageing across the life course”. The research funded will aim to generate new insights on the factors that enable individuals to live actively and healthily into later life. Applications are invited from multidisciplinary research groups representing three to five funding countries. Stage-one pre-proposals can be submitted until 3 October 2011 under three areas:
1. Generate new knowledge on the biological, clinical, behavioural, social and environmental factors that enable individuals to live actively and healthily into later life.
2. Explore comparatively different models, methods, approaches and good practices in societal responses to increased longevity which emphasise both social inclusion and sustainability.
3. Engage in effective knowledge exchange activities that will assist European and other countries to achieve the goal of increasing healthy life expectancy by two years by 2020.











Official book launch at Bournemouth University
Take a Break: Join the Creative Wellbeing Event
Psychology, Psychiatry and Neuroscience academics – would you like to get more involved in preparing our next REF submission?
Three Minute Thesis (3MT®) 2026: Register to Support our PGRs
Horizon Europe Cluster 3 (Civil Security for Society) 2026 Calls Now Open
MSCA Doctoral Networks 2026 Call Information Webinar
ESRC Festival of Social Science 2026: Application Deadline Extended to Thursday 25 June 2026
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease